Home Contact Us Site Map
Search for:
About Us Services News Calendar
Health Info Find a Job Find a Physician
Hospitals
Children’s Hospital
Clinic
Health Plans
Ways to Give
Areas of Excellence
Web Nursery
For Patients and Visitors
E-mail a Patient
Patient Pre-registration
For Physicians,
Co-workers and Volunteers
Libraries
Privacy Practices and Web Use Information
 
Home > Healthy People > January 2004 

                                                                   Winter 2004

St. John’s Eye Specialists among first in U.S. to use new cataract lens

Wendell Scott. M.D., James Gessler, M.D., Craig Peterson, M.D., and Ronald Swendris, M.D.at St. John’s Clinic – Eye Specialists have helped introduce a revolutionary advance in cataract surgery. The AcrySof Natural intraocular lens is the first foldable lens for cataract surgery patients that are specifically designed to filter blue light. Research suggests that blue light may be a factor in causing the onset of age-related macular degeneration, one of the leading causes of blindness in the world.

IMPROVED QUALITY OF LIFE

When an eye surgeon removes a cataract, he or she inserts an artificial intraocular lens. The new lens approximates the natural defense of the human eye and effectively filters blue light. The foldable nature of the lens allows insertion through a small incision.
“With this new intraocular lens, we are able to offer patients the improved quality of life afforded by cataract surgery, plus the added benefit of filtering blue light,” says Gessler, St. John’s ophthalmology section chair.
Cataracts and age-related macular degeneration are medical conditions often found in the aging population. Cataract surgery is the most common surgery performed at St. John’s, Scott says.
“People with the advanced stages of macular degeneration cannot focus, read, tell time, see faces, drive, write checks or do other close-up work. It is an irreversible, progressive disease. Smoking, hypertension, diet and genetics also serve as risk factors for age-related macular degeneration,” he adds.
While many conditions contribute to cataracts and macular degeneration and no one solution represents a cure, the blue-light filtering characteristic of the lens may address one potential risk factor – the lens features a yellow, blue-light absorbing chromophore bound in the implant material to safely and effectively filter high-energy blue light, in addition to a UV light-absorbing chromophore. While this lens provides increased blue-light filtration, it does not alter color vision, or the ability to see under dim light conditions.
“A growing body of evidence shows high-frequency blue light may cause retinal damage,” says Robert Cionni, M.D., medical director of the Cincinnati Eye Institute and clinical investigator of the AcrySof Natural lens.
He added that the lens filters out this potentially dangerous light without negative visual consequences.
“I plan on using this lens as my standard implant,” Scott explains. “It’s going to provide better long-term protection and is one of those easy issues, because there are no added side effects for the patient – only more protection and better benefits."


 
A member of the
Sisters of Mercy Health System